Dr. Diksha Jindal is Professor and Head of the Department of Pharmaceutical Chemistry at the Adesh Institute of Pharmacy and Biomedical Science(AIPBS), Adesh University in Bathinda, India. She holds a Master’s degree in Pharmaceutical Analysis and a PhD in Pharmaceutical Chemistry with more than 14 years of experience in teaching, research, and academic administration. Her research interests include pharmaceutical chemistry, drug delivery systems, pharmaceutical analysis, natural products, microbiome therapeutics, and advanced healthcare technologies. Dr. Jindal has authored and edited multiple books with renowned international publishers. She has published numerous research articles in reputed journals, holds multiple Indian and international patents, and is a member of the American Chemical Society, the American Society for Microbiology, the British Society for Antimicrobial Chemotherapy, and the International Natural Product Sciences Taskforce (INPST). Dr. Itishree Jogamaya Das is a Professor in the Faculty of Medical Science and Research at SNU, Ranchi. She holds an MPharm from Biju Patnaik University of Technology, Rourkela, and a PhD in Pharmaceutics from the Birla Institute of Technology, Mesra. With over 15 years of teaching/research experience, Dr. Das has made significant contributions to the academic and scientific communities. Her expertise lies in formulation development, novel drug delivery systems, nanomedicine, polymeric scaffolds, and tissue regeneration and repair. Her research is particularly focused on the development of multifunctional smart biomaterials for regenerative medicine. She works extensively on polysaccharide-based, stimulus-responsive hydrogels that exhibit self-healing capabilities, mechanical robustness, and targeted drug delivery potential, making them highly promising for applications in tissue engineering and regenerative therapies. A prolific researcher, Dr. Das has authored numerous peer-reviewed articles in high-impact journals, contributed chapters to academic books, and holds several patents in her field of specialization.Dr. Himansu Bhusan Samal is working as an Associate Professor & Associate Dean at the School of Pharmacy and Life Sciences, Centurion University of Technology and Management, Bhubaneswar, Odisha (NAAC A+ Accredited). In addition, he serves as the IQAC coordinator for the School of Pharmacy. Previously, he served as Assistant Professor at Guru Nanak Institutions Technical Campus’s School of Pharmacy in Hyderabad (an autonomous, UGC, NBA, and NAAC A+ accredited institution). With decades of experience in teaching and research, Dr. Samal has published 50 peer-reviewed research papers in national and international journals, authored 16 insightful book chapters, and holds 10 patents. A dedicated mentor and life member of APTI, he has guided more than 30 M. Pharm students and currently supervises 5 Ph.D. scholars. His core research interests include QBD-enabled formulation design, periodontal drug delivery, hydrogel-based wound healing, solubility enhancement, nanoparticulate and mucoadhesive drug delivery. Abhay P. Mishra, Ph.D., is an Academic Researcher at the Department of Pharmaceutical Chemistry, Hemvati Nandan Bahuguna Garhwal University, Srinagar Garhwal-246174, Uttarakhand, India, since Sept. 2010. Prior to joining Garhwal University, he held the position of Lecturer at the Department of Pharmaceutical Chemistry, Uttaranchal College of Science and Technology, Dehradun, Uttarakhand, India. He has vast experience in the field of teaching and research. He has published many peer-reviewed scientific articles, books and presented papers at many national and international conferences. He is acting as a reviewer for many journals and has extensive professional affiliations. He is a seasoned researcher, filed an Indian patent (Published) on Nutraceutical tablet formulation from the high altitude medicinal plant of the Indian Himalayan Region. A. P. Mishra having interests in Phytochemistry, Natural Product Research, Analytical Method Development, and Herbal Formulation Development. He has won several academic awards. Dr. Murali Yallapu is a tenured Professor at the University of Texas Rio Grande Valley's School of Medicine, specializing in Immunology, Microbiology,Toxicology and Oncology and a member of the South Texas Center of Excellence in Cancer Research. Dr. Yallapu received the "Prof. A. Kameswara Rao's Gold Medal-1999" and completed postdoctoral training in materials science, drug delivery, nanomedicine, and cancer biology at institutions including the Cleveland Clinic and the University of Nebraska Medical Center. Before joining UTRGV, he was an Assistant Professor at the University of Tennessee Health Science Center. Dr. Yallapu serves on editorial boards for various journals related to drug delivery, nanotechnology, and cancer, and is an ad-hoc reviewer for the NIH and other funding agencies. He has published over 190 peer-reviewed articles and reviews. His current research primarily focuses on the development of nanomaterials for improved therapeutic potential of clinical drug(s) and developing new constructs for biomedical applications. Additionally, through Cancer Immunology Institute, he is working to generate safe and effective nanoformulations for cancer immunotherapy.